BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

eXegenics (EXEG) Announces Results Of Consent Solicitation; Five Nominees O The Meyers-Weiss Group Were Elected As Directors Of eXegenics, Replacing The Former Board Of Directors


10/19/2005 5:09:28 PM

DALLAS, Dec. 9 /PRNewswire-FirstCall/ -- eXegenics Inc. today announced that IVS Associates, Inc., the proxy inspectors engaged by eXegenics to provide an independent tabulation of the consents and revocations submitted in connection with the Meyers-Weiss Group consent solicitation, reported that the votes cast were sufficient to elect a new slate of directors. As a result, five nominees of the Meyers-Weiss Group were elected as directors of eXegenics, replacing the former board of directors. eXegenics stated that its officers and employees were awaiting instructions from the new board in order to effectuate the orderly transfer of corporate authority.

(Logo: http://www.newscom.com/cgi-bin/prnh/20030312/NYW013LOGO ) Safe Harbor

This release contains forward-looking statements. The words "believe," "expect," "intend", "anticipate," variations of such words, and similar expressions identify forward-looking statements, but their absence does not mean that the statement is not forward-looking. These statements are subject to certain risks, uncertainties and assumptions that are difficult to predict. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. eXegenics undertakes no obligation to update any forward-looking statement to reflect new information, events or circumstances after the date of this release or to reflect the occurrence of unanticipated events.

Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20030312/NYW013LOGOAP Archive: http://photoarchive.ap.org/PRN Photo Desk, photodesk@prnewswire.comeXegenics Inc.

CONTACT: WaLisa M. Davenport of eXegenics Inc., +1-214-358-2000; orWilliam Fiske, Information Agent of Georgeson Shareholder Communications Inc.,+1-800-964-0733, or Banks and Brokers, +1-212-440-9800, for eXegenics Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES